Rational Design of Affinity Improvement of Dengue 4e11 Antibody
The present invention provides, among other things, antibody agents (e.g., antibodies, and/or antigen-binding fragments thereof) that bind to DV epitopes, as well as compositions containing them and methods of designing, providing, formulating, using, identifying and/or characterizing them. In some embodiments, provided antibody agents show significant binding to a plurality of DV serotypes. In some embodiments, provided antibody agents show significant binding to all four DV serotypes. Such antibody agents are useful, for example, in the prophylaxis, treatment, diagnosis, and/or study of DV.
Researchers
-
anti-dengue virus antibodies and uses thereof
Spain | Granted | 2,882,453 -
anti-dengue virus antibodies and uses thereof
United States of America | Granted | 9,499,607 -
anti-dengue virus antibodies and uses thereof
Sri Lanka | Granted | 18,103 -
anti-dengue virus antibodies and uses thereof
Mexico | Granted | 366,886 -
anti-dengue virus antibodies and uses thereof
European Patent Convention | Granted | 2,882,453 -
anti-dengue virus antibodies and uses thereof
Australia | Granted | 2,018,203,152 -
anti-dengue virus antibodies and uses thereof
Japan | Granted | 6,605,643 -
rational design of affinity improvement of dengue 4e11 antibody
Mexico | Granted | 410,163 -
anti-dengue virus antibodies and uses thereof
Singapore | Granted | 11,201,500,605 -
anti-dengue virus antibodies and uses thereof
Canada | Granted | 2,879,994 -
anti-dengue virus antibodies and uses thereof
Japan | Granted | 6,297,560 -
anti-dengue virus antibodies and uses thereof
Israel | Granted | 236,838 -
anti-dengue virus antibodies and uses thereof
Brazil | Granted | 112,015,002,605 -
anti-dengue virus antibodies and uses thereof
Australia | Granted | 2,013,299,986 -
anti-dengue virus antibodies and uses thereof
China | Granted | 104,768,574 -
anti-dengue virus antibodies and uses thereof
Korea (south) | Granted | 10 -
anti-dengue virus antibodies and uses thereof
Hong Kong | Granted | 1,210,054 -
anti-dengue virus antibodies and uses thereof
Hong Kong | Granted | 1,211,851 -
anti-dengue virus antibodies and uses thereof
United States of America | Granted | 9,880,167 -
anti-dengue virus antibodies and uses thereof
Germany | Granted | 2,882,453 -
anti-dengue virus antibodies and uses thereof
United Kingdom | Granted | 2,882,453 -
anti-dengue virus antibodies and uses thereof
France | Granted | 2,882,453 -
anti-dengue virus antibodies and uses thereof
Italy | Granted | 2,882,453
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.